Cargando…

Podocyte Infolding Glomerulopathy, First Case Report From North America

RATIONALE: Podocyte infolding glomerulopathy (PIG) is a newly described condition with only 37 cases reported worldwide. Due to its rarity, the pathogenesis and evolution of this disease is unclear. This case report contributes to our collective knowledge about the clinical and histological progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Julie Anne, Hung, Wayne, McRae, Susanna A., Barbour, Sean J., Copland, Michael, Riazy, Maziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516371/
https://www.ncbi.nlm.nih.gov/pubmed/34659774
http://dx.doi.org/10.1177/20543581211048357
_version_ 1784583791450259456
author Ting, Julie Anne
Hung, Wayne
McRae, Susanna A.
Barbour, Sean J.
Copland, Michael
Riazy, Maziar
author_facet Ting, Julie Anne
Hung, Wayne
McRae, Susanna A.
Barbour, Sean J.
Copland, Michael
Riazy, Maziar
author_sort Ting, Julie Anne
collection PubMed
description RATIONALE: Podocyte infolding glomerulopathy (PIG) is a newly described condition with only 37 cases reported worldwide. Due to its rarity, the pathogenesis and evolution of this disease is unclear. This case report contributes to our collective knowledge about the clinical and histological progression of this disease. PRESENTING CONCERNS OF THE PATIENT: Over the course of a year, a 52-year-old Malaysian woman with no known prior medical history developed progressively worsening edema and other findings consistent with nephrotic syndrome. DIAGNOSIS: Unlike most patients with PIG, this patient did not have any autoimmune disease. She was Hepatitis B core antibody positive with a Hepatitis B surface antibody >1000, suggesting prior Hepatitis B infection with immunity. A renal biopsy was performed which was consistent with PIG. A second renal biopsy was done 2 years later which again showed characteristic findings of PIG with worsened podocyte effacement but no interval change in chronicity. INTERVENTIONS: The patient was treated with blood pressure control and renin-angiotensin-aldosterone system (RAAS) blockade with irbesartan and spironolactone. She was also treated with prednisone at 1 mg/kg for 2 months followed by a taper for a total of 7 months of prednisone treatment. OUTCOMES: The patient had a partial response to a course of prednisone. However, since stopping steroids, her proteinuria and renal function has been gradually worsening. TEACHING POINTS: PIG is mostly found in patients of East Asian descent. It presents as proteinuria and is often associated with autoimmune disease but can be idiopathic. It is characterized on renal biopsy by infolding or protrusion of podocyte cytoplasm into glomerular basement membrane, as well as intramembranous cytoplasmic microspherules or microtubules. Atypical membranous nephropathy should be ruled out prior to diagnosis. Unlike membranous nephropathy, PIG usually responds at least partially to steroid monotherapy. To our knowledge, this is the first reported case of PIG from North America. Furthermore, it is the first case of PIG with repeat biopsy showing interval worsening of PIG rather than either resolution of PIG or transformation of PIG to a different diagnosis.
format Online
Article
Text
id pubmed-8516371
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-85163712021-10-15 Podocyte Infolding Glomerulopathy, First Case Report From North America Ting, Julie Anne Hung, Wayne McRae, Susanna A. Barbour, Sean J. Copland, Michael Riazy, Maziar Can J Kidney Health Dis Educational Case Report RATIONALE: Podocyte infolding glomerulopathy (PIG) is a newly described condition with only 37 cases reported worldwide. Due to its rarity, the pathogenesis and evolution of this disease is unclear. This case report contributes to our collective knowledge about the clinical and histological progression of this disease. PRESENTING CONCERNS OF THE PATIENT: Over the course of a year, a 52-year-old Malaysian woman with no known prior medical history developed progressively worsening edema and other findings consistent with nephrotic syndrome. DIAGNOSIS: Unlike most patients with PIG, this patient did not have any autoimmune disease. She was Hepatitis B core antibody positive with a Hepatitis B surface antibody >1000, suggesting prior Hepatitis B infection with immunity. A renal biopsy was performed which was consistent with PIG. A second renal biopsy was done 2 years later which again showed characteristic findings of PIG with worsened podocyte effacement but no interval change in chronicity. INTERVENTIONS: The patient was treated with blood pressure control and renin-angiotensin-aldosterone system (RAAS) blockade with irbesartan and spironolactone. She was also treated with prednisone at 1 mg/kg for 2 months followed by a taper for a total of 7 months of prednisone treatment. OUTCOMES: The patient had a partial response to a course of prednisone. However, since stopping steroids, her proteinuria and renal function has been gradually worsening. TEACHING POINTS: PIG is mostly found in patients of East Asian descent. It presents as proteinuria and is often associated with autoimmune disease but can be idiopathic. It is characterized on renal biopsy by infolding or protrusion of podocyte cytoplasm into glomerular basement membrane, as well as intramembranous cytoplasmic microspherules or microtubules. Atypical membranous nephropathy should be ruled out prior to diagnosis. Unlike membranous nephropathy, PIG usually responds at least partially to steroid monotherapy. To our knowledge, this is the first reported case of PIG from North America. Furthermore, it is the first case of PIG with repeat biopsy showing interval worsening of PIG rather than either resolution of PIG or transformation of PIG to a different diagnosis. SAGE Publications 2021-10-12 /pmc/articles/PMC8516371/ /pubmed/34659774 http://dx.doi.org/10.1177/20543581211048357 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Educational Case Report
Ting, Julie Anne
Hung, Wayne
McRae, Susanna A.
Barbour, Sean J.
Copland, Michael
Riazy, Maziar
Podocyte Infolding Glomerulopathy, First Case Report From North America
title Podocyte Infolding Glomerulopathy, First Case Report From North America
title_full Podocyte Infolding Glomerulopathy, First Case Report From North America
title_fullStr Podocyte Infolding Glomerulopathy, First Case Report From North America
title_full_unstemmed Podocyte Infolding Glomerulopathy, First Case Report From North America
title_short Podocyte Infolding Glomerulopathy, First Case Report From North America
title_sort podocyte infolding glomerulopathy, first case report from north america
topic Educational Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516371/
https://www.ncbi.nlm.nih.gov/pubmed/34659774
http://dx.doi.org/10.1177/20543581211048357
work_keys_str_mv AT tingjulieanne podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica
AT hungwayne podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica
AT mcraesusannaa podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica
AT barbourseanj podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica
AT coplandmichael podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica
AT riazymaziar podocyteinfoldingglomerulopathyfirstcasereportfromnorthamerica